Donate and Support Live-Saving Research

Your donation directly funds groundbreaking research and advanced treatments to help save lives, reduce harsh side effects and, most importantly, give children options for a better and longer life. In 2024, No More Kids with Cancer decided to direct all donations towards finding better options for high-risk brain tumors. We established the High-Risk Brain Tumor Fund at the Children’s Hospital of Philadelphia. With a $500,000 seed donation, we aim to raise another $1,000,000 focused on finding better options and treatments.

We are asking our supporters to donate directly to the Children’s Hospital of Philadelphia’s High-Risk Brain Tumor Fund. The fund is led by a team of world-recognized scientists and clinicians who also knew Naya.

About The High-Risk Brain Tumor Fund

The High-Risk Brain Tumor Fund continues Naya’s wish to find better options for children, and supports a body of work and team to advance options for children with high-risk brain tumors. The Fund invests in laboratory work to accelerate the ability to get potential treatments to children, while supporting ongoing clinical trials evaluating new therapies for children with high-risk brain tumors and providing treatment options to families in challenging circumstances.

Brain tumors are the leading cause of cancer-related death in children. Although strides have been made in improving outcomes for some pediatric brain tumors, others, such as high-grade gliomas and high-risk medulloblastoma have no curative therapy today, and the majority of children will not survive. There is an urgent need to find better treatments these tumors.  

About the Team

The Children’s Hospital of Philadelphia’s neuro-oncology team is internationally recognized and consistently ranked one of the top programs for pediatric cancer. The Neuro-Oncology Program at Children’s Hospital of Philadelphia (CHOP) is one of the largest programs dedicated to pediatric brain and nervous system tumors, treating over 1,300 unique patients every year. CHOP is at the forefront of promising brain tumor research and care, driving innovation in personalized cancer therapies. Every day, the Neuro-Oncology team at CHOP work tirelessly to help more children and their families along the path from cancer patient to cancer survivor. Their labs are focused on rapidly evaluating novel targeted therapies and immunotherapies to find promising approaches for children. And CHOP’s clinical research program, with over 80 open studies, is testing new treatments for children with brain tumors.    

 CHOP also plays a critical leadership role in several pediatric brain tumor clinical trials consortia (CONNECT and PNOC), as well as numerous other multi-institutional research networks. Through these networks, CHOP is able to magnify its impact more broadly.